Page last updated: 2024-09-03

n 0734 and preclamol

n 0734 has been researched along with preclamol in 1 studies

Compound Research Comparison

Studies
(n 0734)
Trials
(n 0734)
Recent Studies (post-2010)
(n 0734)
Studies
(preclamol)
Trials
(preclamol)
Recent Studies (post-2010) (preclamol)
7042408
704363520

Protein Interaction Comparison

ProteinTaxonomyn 0734 (IC50)preclamol (IC50)
DRattus norvegicus (Norway rat)0.93
D(3) dopamine receptorRattus norvegicus (Norway rat)0.93
D(1B) dopamine receptorRattus norvegicus (Norway rat)0.93
D(4) dopamine receptorRattus norvegicus (Norway rat)0.93
D(2) dopamine receptorRattus norvegicus (Norway rat)2.0703
Sigma non-opioid intracellular receptor 1Rattus norvegicus (Norway rat)0.1599

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bøgesø, KP; Carlsson, A; Hyttel, J; Liljefors, T; Svensson, K; Wikström, H1

Other Studies

1 other study(ies) available for n 0734 and preclamol

ArticleYear
Pre- and postsynaptic dopaminergic activities of indolizidine and quinolizidine derivatives of 3-(3-hydroxyphenyl)-N-(n-propyl)piperidine (3-PPP). Further developments of a dopamine receptor model.
    Journal of medicinal chemistry, 1990, Volume: 33, Issue:3

    Topics: 3,4-Dihydroxyphenylacetic Acid; 5-Hydroxytryptophan; Animals; Dopamine Agents; Dopamine Antagonists; Male; Models, Structural; Molecular Conformation; Motor Activity; Piperidines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Structure-Activity Relationship

1990